FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094920486> ?p ?o ?g. }

• W3094920486 abstract "Abstract Background The goal of our study is to investigate whether the methylation levels of AHCY and CBS promoters are related to the risk of cerebral infarction by detecting the methylation level of AHCY and CBS genes. Methods We extracted peripheral venous blood from 152 patients with cerebral infarction and 152 gender- and age-matched healthy controls, and determined methylation levels of AHCY and CBS promoters using quantitative methylation-specific polymerase chain reaction. We used the percentage of methylation reference (PMR) to indicate gene methylation level. Results We compared the promoter methylation levels of two genes (AHCY and CBS) in peripheral blood DNA between the cerebral infarction case group and the control group. Our study showed no significant difference in AHCY promoter methylation between case and control. Subgroup analysis by gender showed that the methylation level of AHCY in males in the case group was lower than that in the control group, but the difference was not statistically significant in females. In a subgroup analysis by age, there was no significant difference in the AHCY methylation level between the case and control in the young group (≤44 years old). However, the level of AHCY gene methylation in the middle-aged group (45–59 years old) was significantly higher and the aged group (≥60 years old) was significantly lower than that in the control groups. However, CBS promoter methylation levels were significantly lower in the case group than in the control group (median PMR: 70.20% vs 104.10%, P = 3.71E-10). In addition, the CBS methylation levels of males and females in the case group were significantly lower than those in the control group (male: 64.33% vs 105%, P = 2.667E-08; female: 78.05% vs 102.8%, P = 0.003). We also found that the CBS levels in the young (23–44), middle-aged (45–59), and older (60–90) groups were significantly lower than those in the control group (young group: 69.97% vs 114.71%; P = 0.015; middle-aged group: 56.04% vs 91.71%; P = 6.744E-06; older group: 81.6% vs 119.35%; P = 2.644E-04). Our ROC curve analysis of CBS hypomethylation showed an area under the curve of 0.713, a sensitivity of 67.4%, and a specificity of 74.0%. Conclusion Our study suggests that hypomethylation of the CBS promoter may be closely related to the risk of cerebral infarction and may be used as a non-invasive diagnostic biomarker for cerebral infarction." @default.
• W3094920486 created "2020-11-09" @default.
• W3094920486 creator A5005211285 @default.
• W3094920486 creator A5005597238 @default.
• W3094920486 creator A5006763926 @default.
• W3094920486 creator A5021249077 @default.
• W3094920486 creator A5030466570 @default.
• W3094920486 creator A5032396875 @default.
• W3094920486 creator A5039909193 @default.
• W3094920486 creator A5040945443 @default.
• W3094920486 creator A5042435594 @default.
• W3094920486 creator A5067930766 @default.
• W3094920486 creator A5069550654 @default.
• W3094920486 creator A5075450278 @default.
• W3094920486 creator A5075517974 @default.
• W3094920486 creator A5091873057 @default.
• W3094920486 date "2020-11-02" @default.
• W3094920486 modified "2023-10-18" @default.
• W3094920486 title "The values of AHCY and CBS promoter methylation on the diagnosis of cerebral infarction in Chinese Han population" @default.
• W3094920486 cites W1972779100 @default.
• W3094920486 cites W1995931698 @default.
• W3094920486 cites W1998913434 @default.
• W3094920486 cites W2002376746 @default.
• W3094920486 cites W2009400527 @default.
• W3094920486 cites W2027547317 @default.
• W3094920486 cites W2048646816 @default.
• W3094920486 cites W2052086138 @default.
• W3094920486 cites W2054284274 @default.
• W3094920486 cites W2056572968 @default.
• W3094920486 cites W2060492710 @default.
• W3094920486 cites W2064539383 @default.
• W3094920486 cites W2078121536 @default.
• W3094920486 cites W2082540661 @default.
• W3094920486 cites W2086684913 @default.
• W3094920486 cites W2099253412 @default.
• W3094920486 cites W2105407919 @default.
• W3094920486 cites W2117988054 @default.
• W3094920486 cites W2141848068 @default.
• W3094920486 cites W2150153888 @default.
• W3094920486 cites W2159862355 @default.
• W3094920486 cites W2324552216 @default.
• W3094920486 cites W2342150662 @default.
• W3094920486 cites W2551455897 @default.
• W3094920486 cites W2557590979 @default.
• W3094920486 cites W2562535631 @default.
• W3094920486 cites W2726595279 @default.
• W3094920486 cites W2916392902 @default.
• W3094920486 cites W2938263308 @default.
• W3094920486 cites W4211201192 @default.
• W3094920486 cites W4243679994 @default.
• W3094920486 doi "https://doi.org/10.1186/s12920-020-00798-7" @default.
• W3094920486 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7607831" @default.
• W3094920486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33138824" @default.
• W3094920486 hasPublicationYear "2020" @default.
• W3094920486 type Work @default.
• W3094920486 sameAs 3094920486 @default.
• W3094920486 citedByCount "2" @default.
• W3094920486 countsByYear W30949204862021 @default.
• W3094920486 countsByYear W30949204862023 @default.
• W3094920486 crossrefType "journal-article" @default.
• W3094920486 hasAuthorship W3094920486A5005211285 @default.
• W3094920486 hasAuthorship W3094920486A5005597238 @default.
• W3094920486 hasAuthorship W3094920486A5006763926 @default.
• W3094920486 hasAuthorship W3094920486A5021249077 @default.
• W3094920486 hasAuthorship W3094920486A5030466570 @default.
• W3094920486 hasAuthorship W3094920486A5032396875 @default.
• W3094920486 hasAuthorship W3094920486A5039909193 @default.
• W3094920486 hasAuthorship W3094920486A5040945443 @default.
• W3094920486 hasAuthorship W3094920486A5042435594 @default.
• W3094920486 hasAuthorship W3094920486A5067930766 @default.
• W3094920486 hasAuthorship W3094920486A5069550654 @default.
• W3094920486 hasAuthorship W3094920486A5075450278 @default.
• W3094920486 hasAuthorship W3094920486A5075517974 @default.
• W3094920486 hasAuthorship W3094920486A5091873057 @default.
• W3094920486 hasBestOaLocation W30949204861 @default.
• W3094920486 hasConcept C101762097 @default.
• W3094920486 hasConcept C104317684 @default.
• W3094920486 hasConcept C126322002 @default.
• W3094920486 hasConcept C150194340 @default.
• W3094920486 hasConcept C190727270 @default.
• W3094920486 hasConcept C2779450755 @default.
• W3094920486 hasConcept C33288867 @default.
• W3094920486 hasConcept C541997718 @default.
• W3094920486 hasConcept C54355233 @default.
• W3094920486 hasConcept C71924100 @default.
• W3094920486 hasConcept C86803240 @default.
• W3094920486 hasConceptScore W3094920486C101762097 @default.
• W3094920486 hasConceptScore W3094920486C104317684 @default.
• W3094920486 hasConceptScore W3094920486C126322002 @default.
• W3094920486 hasConceptScore W3094920486C150194340 @default.
• W3094920486 hasConceptScore W3094920486C190727270 @default.
• W3094920486 hasConceptScore W3094920486C2779450755 @default.
• W3094920486 hasConceptScore W3094920486C33288867 @default.
• W3094920486 hasConceptScore W3094920486C541997718 @default.
• W3094920486 hasConceptScore W3094920486C54355233 @default.
• W3094920486 hasConceptScore W3094920486C71924100 @default.
• W3094920486 hasConceptScore W3094920486C86803240 @default.
• W3094920486 hasIssue "1" @default.
• W3094920486 hasLocation W30949204861 @default.
• W3094920486 hasLocation W30949204862 @default.

• next